We relocated from Harvard University to join forces with the groundbreaking world leaders in cancer research and care here at
Our research focuses on using cutting-edge technologies to identify new activation pathways in very small numbers of blood cells. Using these strategies to study blood cancer stem cells will help us learn how to treat leukemias such as AML more effectively. We are also using these technologies to understand how to improve revolutionary new immunotherapies such as chimeric antigen receptor (CAR) T cells.
We are excited to be joining the vibrant and dynamic community at City of Hope, a world leader in cancer care with a long history of bringing innovative cancer treatments to patients quickly and effectively.